相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。In vivo comparative study of distinct polymeric architectures bearing a combination of paclitaxel and doxorubicin at a synergistic ratio
Hemda Baabur-Cohen et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Smart linkers in polymer-drug conjugates for tumor-targeted delivery
Minglu Chang et al.
JOURNAL OF DRUG TARGETING (2016)
Assessing the therapeutic efficacy of VEGFR-1-targeted polymer drug conjugates in mouse tumor models
Yosi Shamay et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Restoring the oncosuppressor activity of microRNA-34a in glioblastoma using a polyglycerol-based polyplex
Paula Ofek et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2016)
P-selectin is a nanotherapeutic delivery target in the tumor microenvironment
Yosi Shamay et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Inhibition of primary and metastatic tumors in mice by E-selectin-targeted polymer-drug conjugates
Yosi Shamay et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex
Ting Kang et al.
MOLECULAR PHARMACEUTICS (2015)
Dendritic polyglycerol sulfate as a novel platform for paclitaxel delivery: pitfalls of ester linkage
Ana Sousa-Herves et al.
NANOSCALE (2015)
Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients
Sara M. Tolaney et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Stable and Efficient Paclitaxel Nanoparticles for Targeted Glioblastoma Therapy
Qingxin Mu et al.
ADVANCED HEALTHCARE MATERIALS (2015)
Intraoperative visualization of brain tumors with 5-aminolevulinic acid-induced fluorescence
Georg Widhalm
CLINICAL NEUROPATHOLOGY (2014)
Receptor Mediated Cellular Uptake of Low Molecular Weight Dendritic Polyglycerols
Marcelo Calderon et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2014)
Imaging of doxorubicin release from theranostic macromolecular prodrugs via fluorescence resonance energy transfer
Harald R. Krueger et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs
Pengfei Jiang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Mark R. Gilbert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Bevacizumab for Newly Diagnosed Glioblastoma Reply
Olivier L. Chinot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Bevacizumab plus Radiotherapy-Temozolomide for Newly Diagnosed Glioblastoma
Olivier L. Chinot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Synthesis and Biological Evaluation of Radio and Dye Labeled Amino Functionalized Dendritic Polyglycerol Sulfates as Multivalent Anti-Inflammatory Compounds
Dominic Groeger et al.
BIOCONJUGATE CHEMISTRY (2013)
Targeted Delivery of Dendritic Polyglycerol-Doxorubicin Conjugates by scFv-SNAP Fusion Protein Suppresses EGFR+ Cancer Cell Growth
Ahmad Fawzi Hussain et al.
BIOMACROMOLECULES (2013)
Nano-sized polymers and liposomes designed to deliver combination therapy for cancer
Anat Eldar-Boock et al.
CURRENT OPINION IN BIOTECHNOLOGY (2013)
Brain metastases: pathobiology and emerging targeted therapies
Matthias Preusser et al.
ACTA NEUROPATHOLOGICA (2012)
Thrombospondin-1 Mimetic Peptide ABT-898 Affects Neovascularization and Survival of Human Endometriotic Lesions in a Mouse Model
Diane S. Nakamura et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Suppression of Thrombospondin-1 Expression During Uveal Melanoma Progression and Its Potential Therapeutic Utility
Shoujian Wang et al.
ARCHIVES OF OPHTHALMOLOGY (2012)
Administration, distribution, metabolism and elimination of polymer therapeutics
Ela Markovsky et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Prospective Study of Thrombospondin-1 Mimetic Peptides, ABT-510 and ABT-898, in Dogs with Soft Tissue Sarcoma
A. I. Sahora et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2012)
Prospective Identification of Glioblastoma Cells Generating Dormant Tumors
Ronit Satchi-Fainaro et al.
PLOS ONE (2012)
Synthesis of Dendritic Polyglycerol Anions and Their Efficiency Toward L-Selectin Inhibition
Marie Weinhart et al.
BIOMACROMOLECULES (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Therapies using anti-angiogenic peptide mimetics of thrombospondin-1
Jack Henkin et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Development of efficient acid cleavable multifunctional prodrugs derived from dendritic polyglycerol with a poly(ethylene glycol) shell
Marcelo Calderon et al.
JOURNAL OF CONTROLLED RELEASE (2011)
ABT-898 Induces Tumor Regression and Prolongs Survival in a Mouse Model of Epithelial Ovarian Cancer
Nicole Campbell et al.
MOLECULAR CANCER THERAPEUTICS (2011)
The Role of Dimension in Multivalent Binding Events: Structure-Activity Relationship of Dendritic Polyglycerol Sulfate Binding to L-Selectin in Correlation with Size and Surface Charge Density
Marie Weinhart et al.
MACROMOLECULAR BIOSCIENCE (2011)
Size-Dependant Cellular Uptake of Dendritic Polyglycerol
Stephanie Reichert et al.
SMALL (2011)
A Phase 1 Trial of ABT-510 Concurrent With Standard Chemoradiation for Patients With Newly Diagnosed Glioblastoma
Louis B. Nabors et al.
ARCHIVES OF NEUROLOGY (2010)
Structure-biocompatibility relationship of dendritic polyglycerol derivatives
Jayant Khandare et al.
BIOMATERIALS (2010)
Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ε-caprolactone) nanoparticles: In vitro and in vivo evaluation
Hongliang Xin et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Biopharmaceutical drug targeting to the brain
William M. Pardridge
JOURNAL OF DRUG TARGETING (2010)
Glioma Morphology and Tumor-Induced Vascular Alterations Revealed in Seven Rodent Glioma Models by In Vivo Magnetic Resonance Imaging and Angiography
Sabrina Doblas et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2010)
MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
Michael Weller et al.
NATURE REVIEWS NEUROLOGY (2010)
Dendritic polyglycerol sulfates as multivalent inhibitors of inflammation
Jens Dernedde et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Selectins promote tumor metastasis
Heinz Laeubli et al.
SEMINARS IN CANCER BIOLOGY (2010)
The Thrombospondin-1 Mimetic ABT-510 Increases the Uptake and Effectiveness of Cisplatin and Paclitaxel in a Mouse Model of Epithelial Ovarian Cancer
Nicole E. Campbell et al.
NEOPLASIA (2010)
Transcriptional Switch of Dormant Tumors to Fast-Growing Angiogenic Phenotype
Nava Almog et al.
CANCER RESEARCH (2009)
Phase II Trial of Gliadel plus O6-Benzylguanine in Adults with Recurrent Glioblastoma Multiforme
Jennifer A. Quinn et al.
CLINICAL CANCER RESEARCH (2009)
Phase II Trial of Temozolomide Plus O6-Benzylguanine in Adults With Recurrent, Temozolomide-Resistant Malignant Glioma
Jennifer A. Quinn et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
Henry S. Friedman et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
Teri N. Kreisl et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Hydrogel Matrix Entrapping PLGA-Paclitaxel Microspheres: Drug Delivery with Near Zero-Order Release and Implantability Advantages for Malignant Brain Tumour Chemotherapy
Sudhir Hulikal Ranganath et al.
PHARMACEUTICAL RESEARCH (2009)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomas
Kathleen R. Lamborn et al.
NEURO-ONCOLOGY (2008)
Malignant gliomas in adults
Patrick Y. Wen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Phase 2 study of ABT-510 in patients with previously untreated advanced renal cell carcinoma
Scot Ebbinghaus et al.
CLINICAL CANCER RESEARCH (2007)
Targeting selectins and selectin ligands in inflammation and cancer
Steven R. Barthel et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
Chemotherapy delivery issues in central nervous system malignancy: A reality check
Leslie L. Muldoon et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
DOXO-EMCH (INNO-206): the first albumin-binding prodrug of doxorubicin to enter clinical trials
Felix Kratz
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
ABT-510, a modified type 1 repeat peptide of thrombospondin, inhibits malignant glioma growth in vivo by inhibiting angiogenesis
Joshua C. Anderson et al.
CANCER BIOLOGY & THERAPY (2007)
Preclinical evaluation of antiangiogenic thrombospondin-1 peptide mimetics, ABT-526 and ABT-510, in companion dogs with naturally occurring cancers
Anthony Rusk et al.
CLINICAL CANCER RESEARCH (2006)
Barriers to carrier mediated drug and gene delivery to brain tumors
GH Huynh et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Metronomic low-dose chemotherapy boosts CD95-dependent antiangiogenic effect of the thrombospondin peptide ABT-510: A complementation antiangiogenic strategy
R Yap et al.
CLINICAL CANCER RESEARCH (2005)
Phase I safety, pharmacokinetic, and pharmacodynamic study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced cancer
R Hoekstra et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Association of paclitaxel pharmacokinetics with the development of peripheral neuropathy in patients with advanced cancer
S Mielke et al.
CLINICAL CANCER RESEARCH (2005)
Thrombospondin-1 mimetic peptide inhibitors of angiogenesis and tumor growth: Design, synthesis, and optimization of pharmacokinetics and biological activities
F Haviv et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
CD36: A critical anti-angiogenic receptor
R Simantov et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2003)
Intratumoral T cell subset ratios and Fas ligand expression on brain tumor endothelium
JS Yu et al.
JOURNAL OF NEURO-ONCOLOGY (2003)
Synthesis and in vitro efficacy of acid-sensitive poly(ethylene glycol) paclitaxel conjugates
PCA Rodrigues et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Pharmacodynamics of non-break weekly paclitaxel (Taxol) and pharmacokinetics of Cremophor-EL vehicle: results of a dose-escalation study
E Briasoulis et al.
ANTI-CANCER DRUGS (2002)
Pharmacokinetics of the carmustine implant
AB Fleming et al.
CLINICAL PHARMACOKINETICS (2002)
Inhibition of P-selectin specific cell adhesion by a low molecular weight, non-carbohydrate compound, KF38789
S Ohta et al.
INFLAMMATION RESEARCH (2001)
The role of thrombospondin-1 in tumor progression
I Sargiannidou et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2001)
Biodegradable polymer implants to treat brain tumors
H Brem et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Synthesis, characterization, and biological properties of cyanine-labeled somatostatin analogues as receptor-targeted fluorescent probes
K Licha et al.
BIOCONJUGATE CHEMISTRY (2001)
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
WKA Yung et al.
BRITISH JOURNAL OF CANCER (2000)
分享论文
